Physician profile
Asem Salma
NPI 1255645743
$7,482.11
in general payments reported to CMS, 2019-2025
27 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,006 · 2020: $829 · 2021: $1,150 · 2022: $2,123 · 2023: $892 · 2024: $190 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822 · Travel and Lodging: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.41 |
| Travel and Lodging | $551.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,077.64 | 2020-2023 | Aero-Ll, Everest Spinal System, Mesa Spinal System |
| Alphatec Spine, INC | $1,967.73 | 2019-2021 | |
| Medtronic, INC. | $475.59 | 2021-2025 | O-Arm, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Medtronic USA, INC. | $424.54 | 2019-2020 | |
| Boston Scientific Corporation | $403.86 | 2019-2022 | |
| Nevro Corp. | $281.56 | 2019-2021 | |
| Vb Spine LLC | $178.77 | 2025 | Vesuvius, Prolift, Capri Corpectomy Cage System |
| Centinel Spine, LLC | $145.70 | 2020 | |
| Abbvie INC. | $72.17 | 2021-2025 | Botox |
| Collegium Pharmaceutical, INC. | $61.27 | 2021-2022 | |
| 7d Surgical INC. | $61.16 | 2019 | |
| Globus Medical, INC. | $44.47 | 2019-2025 | Fortify, Coalition Agx, Hedron |
| Radius Health, INC. | $44.27 | 2020-2022 | |
| Livanova USA, INC. | $37.38 | 2022-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Abbott Laboratories | $31.72 | 2024-2025 | Proclaim |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $27.73 | 2023 | Qutenza |
| Ipsen Biopharmaceuticals, INC | $21.70 | 2025 | Dysport |
| Merz Pharmaceuticals, LLC | $17.65 | 2021 | |
| Surgalign Spine Technologies, INC. | $17.59 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.70 | 2022 | |
| Lundbeck LLC | $13.23 | 2021 | |
| Amgen INC. | $12.81 | 2021 | |
| Glaxosmithkline, LLC. | $12.04 | 2021 | |
| Janssen Biotech, INC. | $11.37 | 2021 | |
| Orthofix Medical, INC. | $10.07 | 2019 | |
| Penumbra, INC. | $8.39 | 2020 | |
| Omniscient Neurotechnology America LTD | $5.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asem Salma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.